Defiance Daily Target 2X Long LLY ETF Short Interest Down 35.5% in March

The leveraged ETF provides 2x exposure to Eli Lilly stock price movements.

Apr. 15, 2026 at 1:34am

Got story updates? Submit your updates here. ›

A high-contrast, close-up image of the gears, circuits, and machinery that power a financial trading platform, representing the technical infrastructure behind a leveraged ETF tracking a pharmaceutical stock.The complex inner workings of a leveraged ETF that tracks the daily movements of a major pharmaceutical stock.Defiance Today

The Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a significant decline in short interest during March, dropping 35.5% from the previous reporting period. The ETF provides 2x leveraged exposure to the daily share price movement of Eli Lilly and Company (NYSE:LLY).

Why it matters

The drop in short interest suggests reduced bearish sentiment around the Eli Lilly stock and the leveraged ETF that tracks it. This could indicate increased investor confidence in the pharmaceutical company's performance and outlook.

The details

As of March 31st, the LLYX ETF had short interest totaling 63,687 shares, down from 98,761 shares on March 15th. The days-to-cover ratio, which measures the number of days it would take to cover all the short positions, fell to 0.3 days from the previous 0.4 days.

  • The short interest data is as of March 31, 2026.
  • The previous short interest data is from March 15, 2026.

The players

Defiance Daily Target 2X Long LLY ETF

An exchange-traded fund that provides 2x leveraged exposure to the daily share price movement of Eli Lilly and Company.

Thurston Springer Miller Herd & Titak Inc.

An institutional investor that recently purchased a new position in the Defiance Daily Target 2X Long LLY ETF, owning 0.34% of the fund.

Got photos? Submit your photos here. ›

What’s next

Investors will continue to monitor the short interest and trading activity of the Defiance Daily Target 2X Long LLY ETF as an indicator of sentiment around Eli Lilly's stock performance.

The takeaway

The decline in short interest for the Defiance Daily Target 2X Long LLY ETF suggests increased optimism around Eli Lilly's prospects, as the leveraged fund provides 2x exposure to the pharmaceutical company's stock price movements.